# Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke

> **NCT01464307** · PHASE3 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 290 (actual)

## Conditions studied

- Post-stroke Spasticity of the Lower Limb

## Interventions

- **DRUG:** IncobotulinumtoxinA (400 Units)
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01464307
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-08
- **Final completion:** 2015-05
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2016-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464307, "Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01464307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*